Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Go back to Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 56.92 -0.85 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.77 | 52 Week High | $3.48 | |||
| Open | $57.78 | 52 Week Low | $0.80 | |||
| Day High | $57.99 | P/E | N/A | |||
| Day Low | $56.89 | EPS | $-1.54 | |||
| Volume | 3,105,646 | |||||
